Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In situ vaccination: Cancer immunotherapy both personalized and off‐the‐shelf
Linda Hammerich, Adam Binder, Joshua Brody
Molecular Oncology (2015) Vol. 9, Iss. 10, pp. 1966-1981
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Targeting drugs to tumours using cell membrane-coated nanoparticles
Ronnie H. Fang, Weiwei Gao, Liangfang Zhang
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 33-48
Closed Access | Times Cited: 459
Macroscale biomaterials strategies for local immunomodulation
Maxence O. Dellacherie, Bo Ri Seo, David Mooney
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 379-397
Closed Access | Times Cited: 217
Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Hanne Locy, Sven de Mey, Wout de Mey, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 212
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity
Eric L. Dane, Alexis Belessiotis‐Richards, Coralie M. Backlund, et al.
Nature Materials (2022) Vol. 21, Iss. 6, pp. 710-720
Open Access | Times Cited: 209
Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally
M. Angela Aznar, Nicola Tinari, Antonio Rullan, et al.
The Journal of Immunology (2016) Vol. 198, Iss. 1, pp. 31-39
Open Access | Times Cited: 200
Trial Watch: Toll-like receptor agonists in cancer immunotherapy
Melody Smith, Elena García-Martínez, Michael Pitter, et al.
OncoImmunology (2018) Vol. 7, Iss. 12, pp. e1526250-e1526250
Open Access | Times Cited: 200
Phase I Trial of Intratumoral Injection ofCCL21Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration
Jay M. Lee, Mi-Heon Lee, Edward B. Garon, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 16, pp. 4556-4568
Open Access | Times Cited: 183
Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity
Yingzhong Li, Zhijun Su, Weiyu Zhao, et al.
Nature Cancer (2020) Vol. 1, Iss. 9, pp. 882-893
Open Access | Times Cited: 178
Natural Products and Synthetic Analogs as a Source of Antitumor Drugs
Javad Sharifi‐Rad, Adem Ozleyen, Tugba Boyunegmez Tumer, et al.
Biomolecules (2019) Vol. 9, Iss. 11, pp. 679-679
Open Access | Times Cited: 158
Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer Immunotherapy
Yu Zhang, Sheng Ma, Xinming Liu, et al.
Advanced Materials (2021) Vol. 33, Iss. 7
Closed Access | Times Cited: 155
A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid Tumors
Lingxiao Zhang, Jing Zhao, Xi Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 41
Closed Access | Times Cited: 117
ER-Targeting PDT Converts Tumors into In Situ Therapeutic Tumor Vaccines
Xu Liu, Yu Liu, Xiang Li, et al.
ACS Nano (2022) Vol. 16, Iss. 6, pp. 9240-9253
Closed Access | Times Cited: 93
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review
Mariusz Kaczmarek, Justyna Poznańska, Filip Fechner, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2159-2159
Open Access | Times Cited: 91
Biomimetic and bioinspired nano‐platforms for cancer vaccine development
Chenchao Feng, Peng Tan, Guangjun Nie, et al.
Exploration (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 75
Ferroptosis and Necroptosis Produced Autologous Tumor Cell Lysates Co-Delivering with Combined Immnoadjuvants as Personalized In Situ Nanovaccines for Antitumor Immunity
Wanrui Shi, Wenjie Feng, Siyuan Li, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 14475-14493
Closed Access | Times Cited: 47
Enhancing in situ cancer vaccines using delivery technologies
Ningqiang Gong, Mohamad‐Gabriel Alameh, Rakan El‐Mayta, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 607-625
Closed Access | Times Cited: 22
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 18
Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles
Xiao Cheng, Brian S. Henick, Ke Cheng
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6748-6765
Closed Access | Times Cited: 17
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Matthew J. Frank, Patrick M. Reagan, Nancy L. Bartlett, et al.
Cancer Discovery (2018) Vol. 8, Iss. 10, pp. 1258-1269
Open Access | Times Cited: 152
White paper on microbial anti-cancer therapy and prevention
Neil S. Forbes, Robert S. Coffin, Liang Deng, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 141
Plant viruses and bacteriophages for drug delivery in medicine and biotechnology
Anna E. Czapar, Nicole F. Steinmetz
Current Opinion in Chemical Biology (2017) Vol. 38, pp. 108-116
Open Access | Times Cited: 110
A Designer Scaffold with Immune Nanoconverters for Reverting Immunosuppression and Enhancing Immune Checkpoint Blockade Therapy
Hathaichanok Phuengkham, Chanyoung Song, Yong Taik Lim
Advanced Materials (2019) Vol. 31, Iss. 42
Closed Access | Times Cited: 107
Immunoadjuvants for cancer immunotherapy: A review of recent developments
Asmita Banstola, Jee‐Heon Jeong, Simmyung Yook
Acta Biomaterialia (2020) Vol. 114, pp. 16-30
Closed Access | Times Cited: 106
Biomimetic Nanoparticle Vaccines for Cancer Therapy
Ashley V. Kroll, Yao Jiang, Jiarong Zhou, et al.
Advanced Biosystems (2018) Vol. 3, Iss. 1
Open Access | Times Cited: 99
Page 1 - Next Page

Scroll to top